WHO ICTRP trial
A clinical study of treatment efficacy and safety of inactive HBsAg carrier
ChiCTR-OPN-15007410 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-OPN-15007410 |
|---|---|
| Public title | A clinical study of treatment efficacy and safety of inactive HBsAg carrier |
| Scientific title | A clinical study of treatment efficacy and safety of inactive HBsAg carrier |
| Primary sponsor | Beijing You’an Hosipital, Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | Post-market |
| Countries | China |
| Conditions | inactive HBsAg carrier |
| Interventions | A:pegIFN alfa 2a 135ug/week or combine with adefovir 10mg/day, for 96weeks;B:no antiviral therapy |
| Registration date | Nov 12, 2015 |
| Target size | A:100;B:100 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: